16th Biennial ISAKOS Congress (ISAKOS Congress 2027)

Abstract Submission | ISAKOS 2027
Share your research at ISAKOS 2027 in Sydney. Submit abstracts for podium or poster presentation by August 4. Outstanding work considered for ISAKOS Awards.

ISAKOS Congress Call for Abstracts
ACCME Standards for Integrity and Independence in Accredited Continuing Education require providers to mitigate relevant financial relationships to prevent commercial bias and disclose the presence or absence of all relevant financial relationships to learners prior to the activity. According to Standard 3.2 of the ACCME Standards for Integrity and Independence in Accredited Continuing Education, “Owners and employees of ineligible companies must be excluded from controlling content or participating as planners or faculty in accredited education”. The Presenting Author of any accepted abstract /poster cannot be employed by an ACCME- defined ineligible company*. Employees of ineligible companies are prohibited from having any role in the planning or implementation of CME activities related to the ineligible company’s business lines or products. *An ineligible company (formerly called a commercial interest) is one whose primary business is producing, marketing, re-selling, or distributing health care products used by, on patients. The ACCME does not consider providers of clinical service directly to patients to be ineligible companies. You may be required to edit your submission if it is found to be noncompliant with these standards:
ACCME and HIPPA Compliance- All individually identifiable health information regarding a client or patient must be sufficiently edited or modified to ensure HIPPA compliance.
Presentations must give a balanced view of therapeutic options. All recommendations for patient care must be based on current science, evidence, and clinical reasoning.
New and evolving topics must be clearly identified in the presentation slides.